Zentiva AG | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Zentiva AG

BRIEF

published on 11/19/2024 at 21:34, 1 day 13 hours ago

Zentiva Amends Offer for APONTIS PHARMA Shares

Acquisition Shareholders Offer APONTIS PHARMA Zentiva
PRESS RELEASE

published on 11/19/2024 at 21:29, 1 day 13 hours ago

Condition of minimum acceptance in Zentiva’s Voluntary Public Purchase Offer waived – Acceptance Period remains unchanged and ends on 21 November 2024 at 24:00 CET
Zentiva AG waives minimum acceptance condition in APONTIS PHARMA purchase offer, maintaining original timeline. Significant shareholder acceptance received

APONTIS PHARMA Mergers Purchase Offer Zentiva AG Shareholder Acceptance
BRIEF

published on 10/24/2024 at 08:20, 28 days 2 hours ago

APONTIS PHARMA Shareholders Invited to Tender Shares with Premium Offer

Mergers And Acquisitions APONTIS PHARMA Share Tender Offer Zentiva AG Premium Share Price
PRESS RELEASE

published on 10/24/2024 at 08:15, 28 days 2 hours ago

APONTIS PHARMA shareholders can tender their shares from today – Offer Document published
Zentiva AG, a subsidiary of Zentiva Pharma, launches a voluntary public purchase offer for APONTIS PHARMA shares at EUR 10.00 each, representing a 52.9% premium. Management supports the offer

Shareholders APONTIS PHARMA Premium Voluntary Offer Zentiva AG
BRIEF

published on 10/16/2024 at 12:00, 1 month 4 days ago

Zentiva Announces Voluntary Purchase Offer for APONTIS PHARMA

APONTIS PHARMA Investment Agreement Public Purchase Offer Zentiva Pharmaceutical Merger
PRESS RELEASE

published on 10/16/2024 at 11:55, 1 month 4 days ago

Zentiva announces voluntary public purchase offer for APONTIS PHARMA – Investment Agreement signed
Zentiva announces voluntary public purchase offer for APONTIS PHARMA with a 52.9% premium over the closing share price on 15 October 2024. Zentiva to acquire approx. 37.5% stake through share sale and purchase agreement with main shareholder

APONTIS PHARMA Premium Investment Agreement Voluntary Purchase Offer Zentiva

Accesswire

Published on 11/21/2024 at 10:03, 56 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 59 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 59 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 24 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 34 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 29 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 54 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 57 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 59 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 59 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 1 minute ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 39 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 14 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 14 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE